Network News
THE EUROPEAN RESEARCH COUNCIL FINANCES GROUNDBREAKING PROJECTS WITH ERC ADVANCED GRANTS Five scientists from Heidelberg University are each receiving valuable funding from the European Research Council (ERC), an ERC Advanced Grant. These grants are intended for top-flight researchers who are pursuing groundbreaking projects with their work. Two of the grants go to Prof. Dr Loredana […]
read more
Hector Foundation Prize 2025 for Annika Reinke: “Metrics Reloaded” improves the quality of AI-supported image analysis
Computer scientist Annika Reinke from the German Cancer Research Center (DKFZ) has been awarded the Hector Foundation Prize 2025, endowed with €10,000, for her outstanding work in the field of AI-supported medical image analysis. She received the award for the project Metrics Reloaded, which can significantly improve the quality and reliability of AI-supported image analysis. […]
read more
Novel laboratory models pave the way for targeted therapies for childhood sarcomas
Sarcomas in soft tissue usually occur in young people and are particularly difficult to treat. Due to a lack of laboratory models, the causes of their development are still poorly understood. A team of researchers from the Hopp Children’s Cancer Centre Heidelberg (KiTZ), the German Cancer Research Centre (DKFZ) and Heidelberg University Hospital (UKHD) has […]
read more
KEY PROTEINS FOR MALARIA REPRODUCTION FOUND IN THE MOSQUITO
How can the malaria pathogen be prevented from multiplying successfully? Dr Franziska Hentzschel, a scientist at the Medical Faculty of Heidelberg University, has discovered a new approach to this. Her research is reported in the current issue of the renowned journal ‘Nature Microbiology’. Malaria is triggered by the single-celled parasite Plasmodium, which is transmitted to humans […]
read more
PEPperPRINT GmbH launches cLIFT technology for next-generation peptide microarrays
Heidelberg, 10th of June 2025 – PEPperPRINT, a global leader in peptide microarray technology, celebrates its 15th anniversary with the launch of its next-generation peptide microarray platform: cLIFT, short for combinatorial Laser-Induced Forward Transfer. The new technology dramatically expands peptide printing capabilities and paves the way for innovative biomedical research applications. Developed in collaboration with Dr. Felix Loeffler of […]
read more
Clonal hematopoiesis landscape in frequent blood donors
Key Points Abstract Donor blood saves lives, yet the potential impact of recurrent large-volume phlebotomy on donor health and hematopoietic stem cells (HSCs) remains largely unexplored. In our study, we conducted a comprehensive screening of 217 older male volunteer donors with a history of extensive blood donation (>100 lifetime donations) to investigate the phenomenon of […]
read more
Small extracellular vesicles and particles (sEVPs) derived from tumor-free pre-metastatic organs promote breast cancer metastasis and support organotropismNew Collaborative Research Centre on Cancers of Blood-Forming Bone Marrow
Abstract Metastatic breast cancer remains largely incurable, partly due to our incomplete understanding of its intricate underlying mechanisms. Notably, inercellular communication mediated by small extracellular vesicles and particles (sEVPs) has emerged as a key feature of metastasis. While tumor-derived sEVPs have been extensively studied and are known to be pro-metastatic, the role of sEVPs from […]
read more
New Collaborative Research Centre on Cancers of Blood-Forming Bone Marrow
DFG funds research consortium at the Medical Faculty Heidelberg with around 15.8 million euros – A new Collaborative Research Centre based at the Medical Faculty Heidelberg is going to start at Heidelberg University. In its recent approval round, the German Research Foundation (DFG) decided to support CRC 1709 “Cellular Plasticity in Malignant Myeloid Diseases – […]
read more
Strategic alliance for rare diseases: RHEACELL and AOP Health enter into strategic partnership to commercialize novel somatic cell therapies in Europe
Heidelberg/Germany, May 27, 2025. RHEACELL announced today that it has entered into an exclusive partnership agreement with the AOP Health Group, who will commercialize RHEACELL’s two stem cell products, EBESANAR® and AMESANAR®, in Europe, Turkey, Israel and the MENA region (Middle East and Northern Africa). RHEACELL retains full commercialization rights to EBESANAR® and AMESANAR® in […]
read more
